These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 3010100

  • 1. Congenital myasthenia: further evidence of disease heterogeneity.
    Lecky BR, Morgan-Hughes JA, Murray NM, Landon DN, Wray D, Prior C.
    Muscle Nerve; 1986; 9(3):233-42. PubMed ID: 3010100
    [Abstract] [Full Text] [Related]

  • 2. Congenital myasthenia: end-plate acetylcholine receptors and electrophysiology in five cases.
    Vincent A, Cull-Candy SG, Newsom-Davis J, Trautmann A, Molenaar PC, Polak RL.
    Muscle Nerve; 1981; 4(4):306-18. PubMed ID: 7254233
    [Abstract] [Full Text] [Related]

  • 3. Congenital myasthenic syndromes: II. Syndrome attributed to abnormal interaction of acetylcholine with its receptor.
    Uchitel O, Engel AG, Walls TJ, Nagel A, Atassi MZ, Bril V.
    Muscle Nerve; 1993 Dec; 16(12):1293-301. PubMed ID: 8232384
    [Abstract] [Full Text] [Related]

  • 4. Acetylcholine receptor in myasthenia gravis: increased affinity for alpha-bungarotoxin.
    Elias SB, Appel SH.
    Ann Neurol; 1978 Sep; 4(3):250-2. PubMed ID: 718136
    [Abstract] [Full Text] [Related]

  • 5. A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitro.
    Burges J, Wray DW, Pizzighella S, Hall Z, Vincent A.
    Muscle Nerve; 1990 May; 13(5):407-13. PubMed ID: 2345558
    [Abstract] [Full Text] [Related]

  • 6. Newly recognized congenital myasthenic syndrome associated with high conductance and fast closure of the acetylcholine receptor channel.
    Engel AG, Uchitel OD, Walls TJ, Nagel A, Harper CM, Bodensteiner J.
    Ann Neurol; 1993 Jul; 34(1):38-47. PubMed ID: 7685992
    [Abstract] [Full Text] [Related]

  • 7. A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release.
    Engel AG, Lambert EH, Gomez MR.
    Ann Neurol; 1977 Apr; 1(4):315-30. PubMed ID: 214017
    [Abstract] [Full Text] [Related]

  • 8. Congenital canine myasthenia gravis: I. Deficient junctional acetylcholine receptors.
    Oda K, Lambert EH, Lennon VA, Palmer AC.
    Muscle Nerve; 1984 Apr; 7(9):705-16. PubMed ID: 6543919
    [Abstract] [Full Text] [Related]

  • 9. Experimental autoimmune myasthenia gravis: the rabbit as an animal model.
    Eldefrawi ME.
    Fed Proc; 1978 Dec; 37(14):2823-7. PubMed ID: 720635
    [Abstract] [Full Text] [Related]

  • 10. Congenital myasthenic syndromes: I. Deficiency and short open-time of the acetylcholine receptor.
    Engel AG, Nagel A, Walls TJ, Harper CM, Waisburg HA.
    Muscle Nerve; 1993 Dec; 16(12):1284-92. PubMed ID: 8232383
    [Abstract] [Full Text] [Related]

  • 11. Novel truncating RAPSN mutations causing congenital myasthenic syndrome responsive to 3,4-diaminopyridine.
    Banwell BL, Ohno K, Sieb JP, Engel AG.
    Neuromuscul Disord; 2004 Mar; 14(3):202-7. PubMed ID: 15036330
    [Abstract] [Full Text] [Related]

  • 12. Abnormal neuromuscular transmission in an infantile myasthenic syndrome.
    Albers JW, Faulkner JA, Dorovini-Zis K, Barald KF, Must RE, Ball RD.
    Ann Neurol; 1984 Jul; 16(1):28-34. PubMed ID: 6087719
    [Abstract] [Full Text] [Related]

  • 13. End-plate acetylcholinesterase deficiency associated with small nerve terminals and reduced acetylcholine release. A new syndrome.
    Engel AG, Lambert EH, Gomez MR.
    Int J Neurol; 1980 Jul; 14(1):73-86. PubMed ID: 6293992
    [No Abstract] [Full Text] [Related]

  • 14. Deficiency of acetylcholine receptors in a case of end-plate acetylcholinesterase deficiency: a histochemical investigation.
    Jennekens FG, Hesselmans LF, Veldman H, Jansen EN, Spaans F, Molenaar PC.
    Muscle Nerve; 1992 Jan; 15(1):63-72. PubMed ID: 1732764
    [Abstract] [Full Text] [Related]

  • 15. Facilitatory effects of 4-aminopyridine on neuromuscular transmission in disease states.
    Kim YI, Goldner MM, Sanders DB.
    Muscle Nerve; 1980 Jan; 3(2):112-9. PubMed ID: 6245355
    [Abstract] [Full Text] [Related]

  • 16. Passive transfer of seronegative myasthenia gravis to mice.
    Burges J, Vincent A, Molenaar PC, Newsom-Davis J, Peers C, Wray D.
    Muscle Nerve; 1994 Dec; 17(12):1393-400. PubMed ID: 7969240
    [Abstract] [Full Text] [Related]

  • 17. Acquired slow-channel syndrome: a form of myasthenia gravis with prolonged open time of the acetylcholine receptor channel.
    Wintzen AR, Plomp JJ, Molenaar PC, van Dijk JG, van Kempen GT, Vos RM, Wokke JH, Vincent A.
    Ann Neurol; 1998 Oct; 44(4):657-64. PubMed ID: 9778265
    [Abstract] [Full Text] [Related]

  • 18. Dolichos biflorus agglutinin receptors in mouse muscle. I. Developmental expression in relation to synaptic acetylcholinesterase and to neuromuscular disease.
    Kaupmann K, Heimann P, Jockusch H.
    Eur J Cell Biol; 1988 Aug; 46(3):411-8. PubMed ID: 3181163
    [Abstract] [Full Text] [Related]

  • 19. Desensitization of mutant acetylcholine receptors in transgenic mice reduces the amplitude of neuromuscular synaptic currents.
    Bhattacharyya BJ, Day JW, Gundeck JE, Leonard S, Wollmann RL, Gomez CM.
    Synapse; 1997 Dec; 27(4):367-77. PubMed ID: 9372559
    [Abstract] [Full Text] [Related]

  • 20. A non-immunogenic myasthenia gravis model and its application in a study of transsynaptic regulation at the neuromuscular junction.
    Molenaar PC, Oen BS, Plomp JJ, Van Kempen GT, Jennekens FG, Hesselmans LF.
    Eur J Pharmacol; 1991 Apr 10; 196(1):93-101. PubMed ID: 1874282
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.